We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMDZ
1326
DELISTED
Immune Design Corp.
IMDZ
$82K ﹤0.01%
17,959
-137,905
-88% -$549K
NOG icon
1327
Northern Oil and Gas
NOG
$2.35B
$76K ﹤0.01%
+2,414
New +$54.4K
EGLE
1328
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$76K ﹤0.01%
+1,987
New +$75.8K
RRD
1329
DELISTED
RR Donnelley & Sons Co.
RRD
$66K ﹤0.01%
11,389
-15,967
-58% -$118K
HOV icon
1330
Hovnanian Enterprises
HOV
$807M
$63K ﹤0.01%
+1,545
New +$72.9K
ARAY icon
1331
Accuray
ARAY
$34M
$58K ﹤0.01%
14,190
-13,592
-49% -$62.9K
FTD
1332
DELISTED
FTD Companies, Inc. Common Stock
FTD
$58K ﹤0.01%
+12,538
New +$70.2K
CRIS icon
1333
Curis
CRIS
$7.83M
$52K ﹤0.01%
+75
New +$76.8K
TRVN
1334
DELISTED
Trevena, Inc.
TRVN
$44K ﹤0.01%
+48
New +$52.9K
HK
1335
DELISTED
Halcon Resources Corporation
HK
$44K ﹤0.01%
10,000
-473,525
-98% -$2.3M
AUY
1336
DELISTED
Yamana Gold, Inc.
AUY
$41K ﹤0.01%
+14,252
New +$41.4K
KGC icon
1337
Kinross Gold
KGC
$32.8B
$39K ﹤0.01%
10,300
-73,604
-88% -$277K
TRQ
1338
DELISTED
Turquoise Hill Resources Ltd
TRQ
$33K ﹤0.01%
1,170
– –
AVXL icon
1339
Anavex Life Sciences
AVXL
$310M
$32K ﹤0.01%
+12,050
New +$33.7K
AVP
1340
DELISTED
Avon Products, Inc.
AVP
$18K ﹤0.01%
+11,400
New +$24.1K
ONSIW
1341
DELISTED
Oncobiologics, Inc. Series A Warrant Expiring 2/18/2019
ONSIW
$6K ﹤0.01%
125,400
– –
AAP icon
1342
Advance Auto Parts
AAP
$3.49B
– –
-8,011
Closed -$950K
AB icon
1343
AllianceBernstein
AB
$3.47B
– –
-31,650
Closed -$850K
ACCO icon
1344
Acco Brands
ACCO
$407M
– –
-179,304
Closed -$2.25M
ACET icon
1345
Adicet Bio
ACET
$74.7M
– –
-489
Closed -$525K
ACIW icon
1346
ACI Worldwide
ACIW
$5.42B
– –
-50,631
Closed -$1.2M
ACN icon
1347
Accenture
ACN
$108B
– –
-126,801
Closed -$19.5M
AES icon
1348
AES
AES
$10.5B
– –
-2,244,353
Closed -$25.5M
AFG icon
1349
American Financial Group
AFG
$12.1B
– –
-42,820
Closed -$4.81M
AGCO icon
1350
AGCO
AGCO
$7.2B
– –
-484,936
Closed -$31.4M
52 53
54
55 56

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.